Home/Filings/4/0001209191-20-003662
4//SEC Filing

Jansen Burkhard 4

Accession 0001209191-20-003662

CIK 0001651944other

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 4:18 PM ET

Size

5.7 KB

Accession

0001209191-20-003662

Insider Transaction Report

Form 4
Period: 2020-01-14
Jansen Burkhard
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-14+43,12043,120 total
    Exercise: $9.73Exp: 2030-01-14Common Stock (43,120 underlying)
Footnotes (1)
  • [F1]The shares of Issuer common stock exercisable pursuant to this option shall vest in a series of thirty-six (36) successive equal monthly installments commencing one month following January 14, 2020, such that all shares of Issuer common stock exercisable pursuant to this option shall be fully vested on January 14, 2023, subject to the Reporting Person's continued service.

Issuer

DermTech, Inc.

CIK 0001651944

Entity typeother

Related Parties

1
  • filerCIK 0001787132

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:18 PM ET
Size
5.7 KB